Page last updated: 2024-10-31

mirtazapine and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

mirtazapine has been researched along with Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome in 3 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Research Excerpts

ExcerptRelevanceReference
"Mirtazapine was more effective than desipramine in restoring somatosensory cortex thickness by fully rescuing pyramidal neurons dendritic arborization and spine density."5.43Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice. ( Baj, G; Bernareggi, A; Bittolo, T; Deiana, C; Ferrazzo, S; Raminelli, CA; Tongiorgi, E; Vaghi, V, 2016)
"Mirtazapine was more effective than desipramine in restoring somatosensory cortex thickness by fully rescuing pyramidal neurons dendritic arborization and spine density."1.43Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice. ( Baj, G; Bernareggi, A; Bittolo, T; Deiana, C; Ferrazzo, S; Raminelli, CA; Tongiorgi, E; Vaghi, V, 2016)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Flores GutiƩrrez, J2
Natali, G2
Giorgi, J1
De Leonibus, E1
Tongiorgi, E3
De Felice, C1
Leoncini, S1
Signorini, C1
Hayek, J1
Bittolo, T1
Raminelli, CA1
Deiana, C1
Baj, G1
Vaghi, V1
Ferrazzo, S1
Bernareggi, A1

Trials

1 trial available for mirtazapine and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

ArticleYear
Protective role of mirtazapine in adult female Mecp2
    Journal of neurodevelopmental disorders, 2020, 09-28, Volume: 12, Issue:1

    Topics: Animals; Disease Models, Animal; Female; Humans; Methyl-CpG-Binding Protein 2; Mice; Mirtazapine; Re

2020

Other Studies

2 other studies available for mirtazapine and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome

ArticleYear
Mirtazapine treatment in a young female mouse model of Rett syndrome identifies time windows for the rescue of early phenotypes.
    Experimental neurology, 2022, Volume: 353

    Topics: Adolescent; Adult; Animals; Antidepressive Agents; Body Weight; Disease Models, Animal; Female; Huma

2022
Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice.
    Scientific reports, 2016, Jan-25, Volume: 6

    Topics: Animals; Antidepressive Agents; Atrophy; Breath Tests; Cerebral Cortex; Desipramine; GABAergic Neuro

2016